No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Protagonist Therapeutics Set to Join S&P SmallCap 600
Protagonist Therapeutics To Join S&P SmallCap 600, Effective Prior To Opening Of Trading On July 3
Encore Wire (NASDAQ:WIRE) Is Very Good At Capital Allocation
Are You Looking for a Top Momentum Pick? Why Encore Wire (WIRE) Is a Great Choice
Encore Wire, the Prysmian Buyout and Next Picks
Prysmian Obtains US Antitrust Clearance for Encore Wire Acquisition